BMJ Investigation | FDA oversight of clinical trials is “grossly inadequate,” say experts.
25 Nov, 2022 | 12:35h | UTCFDA oversight of clinical trials is “grossly inadequate,” say experts – The BMJ
News Release: Investigation raises concerns about poor FDA oversight of clinical trials – BMJ Newsroom
Commentary: FDA Oversight of Clinical Trials Described as ‘Grossly Inadequate’ – HealthDay